Lars Lindgaard Hansen
Associate Director at Takeda Pharma A/S | Region Zealand, Denmark
Lars Lindgaard Hansen’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Vice President Process Development at IO Biotech in January 2024 - Present
Senior Director Drug Product Development at IO Biotech in December 2021 - March 2024
Senior Drug Product Manager at Ascendis Pharma A/S in January 2020 - November 2021
Senior Manager, Biopharmaceutical Products at LEO Pharma in September 2017 - December 2019
R&D Senior Scientist at LEO Pharma in September 2014 - August 2017
Associate Director at Takeda Pharma A/S in January 2012 - September 2014
Senior Pharmaceutical Scientist at Nycomed Danmark ApS in January 2002 - January 2006
Pharmaceutical Scientist at Pharmexa A/S in January 2000 - January 2002
Chemist at Novo Nordisk Pharmaceuticals in January 1994 - January 2000
Danmarks Farmaceutiske Universitet, PhD
Danmarks Farmaceutiske Universitet, MSc
IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines based on its T-win® platform. The T-win platform is based on a novel approach to cancer vaccines designed to activate T cells to target both tumor cells and the immune-suppressive cells in the tumor microenvironment. IO Biotech is advancing its lead cancer vaccine candidate, Cylembio, in clinical trials, and additional pipeline candidates through preclinical development. IO Biotech is headquartered in Copenhagen, Denmark and has US headquarters in New York, New York. IO Biotech has an experienced management team within the immune-oncology field and a world-class advisory board.
Discover more about Takeda Pharma A/S
Chief Medical Officer ; FFPM Royal College of Physicians, UK; MSc Clinical Oncology; MSc Pharmaceutical Medicine; MSc Global Health Policy
Leading First in Class Immune-modulatory Therapeutic Cancer Vaccine Platform
- Structured Financing
- Operation scale up, corporate growth and market readiness.
- Enterprise development strategies, strengthening credibility with investors, analysts, Business development, opini...
Chief Business Officer at IO Biotech
Chief Business Officer and member of the company's executive team at IO Biotech
(Apr 2024 – Present)
Senior executive with extensive leadership experience in early-late stage drug development including operations, portfolio & program management and commercial expertise scaling and leading organizations
Strategic Procurement Leader | Contract and Vendor Management | Sourcing Excellence
Life Sciences General Counsel | 4x Public Company Executive | Building lean legal, compliance, and governance functions that advance strategy, navigate risk, and drive business results
General Counsel and Chief Compliance Officer at IO Biotech
(Jan 2023 – Present)
VP Precision Medicine & Biomarkers @ IO Biotech | Immuno-Oncology--Cancer--Cell Therapy--Vaccines--Biomarker Development
VP Precision Medicine & Biomarkers at IO Biotech
(Jan 2024 – Present)
What is Lars Lindgaard Hansen email address?
Email Lars Lindgaard Hansen at [email protected]. This email is the most updated Lars Lindgaard Hansen's email found in 2026.
How to contact Lars Lindgaard Hansen?
To contact Lars Lindgaard Hansen send an email to [email protected].
What company does Lars Lindgaard Hansen work for?
Lars Lindgaard Hansen works for Takeda Pharma A/S.
What is Lars Lindgaard Hansen's role at Takeda Pharma A/S?
Lars Lindgaard Hansen is Associate Director
What industry does Lars Lindgaard Hansen work in?
Lars Lindgaard Hansen works in the Pharmaceuticals industry.
